European Biotechnology Magazine Spring 2020 | Special Preview: Bioprocessing

European Biotechnology Spring 2020

Previe0w 20 Spring 2

ŠPT Hamilton/stock.

Bioprocessing

Special

Publication date: 9 April, 2020

Bioprocessing

Get on Board!

Hot topics in bioprocessing As recently reported NK stem cells could provide a way to make CAR cell therapies cheaper because they do not need to be derived from individual patients. New drug formats such as cell & gene therapies, live microbial therapies, conjugates of or engineered antibodies are filling clincical pipelines, new and cost-effective processes are needed to make them a business case. Contract manufacturers that have all the capacities in-house to develop a biologic/advanced therapy GMP compliantly from preclinical stage to the filled & finished product have good chances in the emerging new markets.

Present your expertise in the journal of the official media partner Drug developers, CDMOs and experts will have the opportunity to present their latest research, products, processes, and equipment in this special. European Biotechnology Magazine goes out to decision makers throughout the entire European Life Sciences sector. Take advantage of to the journal’s highly relevant readership and grab this opportunity to target your audience!

Topics to be covered Services & equipment: cell line selection, process development & upscaling, process monitoring, QbD, single use equipment, media development, cell culture, glycoengineering, conjugation, formulation, fill & finish, DSP, continous processing, ex vivo genetic engineering, TCR engineering, IgG-like bispecifics, AAV and lentiviral vector technology, plasmid engineering, modular UPS and DSP, antibody engineering, purification, polishing

Editorial Deadline 23-3-2020

Booking Deadline 27-3-2020

Publication Date 09-4-2020

Editor: Thomas Gabrielczyk Tel.: +49-30-264921-50 Fax: +49-30-264921-11 t.gabrielczyk@biocom.de

Contact Marketing: Oliver Schnell Tel.: +49-30-264921-45 Fax: +49-30-264921-11 o.schnell@biocom.de

Contact Marketing: Andreas Macht Tel.: +49-30-264921-54 Fax: +49-30-264921-11 a.macht@biocom.de

BIOCOM AG I Lützowstraße 33–36 I 10785 Berlin I www.biocom.de

Special: Bioprocessing

Meet your audience!

European Biotechnology is published in co-operation with the following organisations: European Biotechnology NET WORK

Europe: european-biotechnology.net

Europe: medtecheurope.org

Spain: asebio.com

Europe: lifescienceaustria.at

Switzerland: swissbiotech.org

Europe: medicinesforeurope.com

Ireland: ibec.ie/ibia

Denmark: danskbiotek.dk

The Netherlands: hollandbio.nl

Germany: biodeutschland.org

Portugal: www.p-bio.org

Austria:diahome.org

France: france-biotech.org

Council of European BioRegions

CMYK

Italy: assobiotec.it

Sweden: swedenbio.com

Hungary: hungarianbiotech.org

Europe: cebr.net

Europe: ebe-biopharma.org

Norway: biotekforum.no

Finland: finbio.net

Belgium: bio.be

Blue: 100/15/0/35 Orange: 0/75/90/0

European Biotechnology covers the biotechnology sector of the current 27 EU member states, Norway and Switzerland. If you would like to subscribe, please refer to european-biotechnology.com

EBE